Bioavailability can be measured through pharmacokinetic and pharmacodynamic methods. Pharmacokinetic methods involve measuring drug concentrations in blood or amount excreted in urine over time to determine parameters like Cmax, Tmax, and AUC. Pharmacodynamic methods involve measuring acute pharmacological responses or long-term therapeutic responses to a drug. The most common pharmacokinetic method is to collect serial blood samples after drug administration and measure drug concentrations to generate a plasma concentration-time curve from which various pharmacokinetic parameters can be derived. Relative bioavailability is calculated as the ratio of AUCs for a test and reference formulation, while absolute bioavailability is calculated as the ratio of AUCs for an oral and intravenous dose.